MODE OF BINDING OF FOLATE ANALOGS TO THYMIDYLATE SYNTHASE - EVIDENCE FOR 2 ASYMMETRIC BUT INTERACTIVE SUBSTRATE-BINDING SITES

Human thymidylate synthase is a polymeric protein composed of two subunits with identical primary structures. In this study we determined the binding affinities of 5,10-methylene tetrahydropteroyltetraglutamate (folate substrate) and a group of close structural folate analog inhibitors. Thymidylate synthase bound both mono and polyglutamylated folate substrates and analogs more tightly in the presence of deoxyuridylate. These results and product inhibition studies confirmed that the orders of substrate addition and product release from thymidylate synthase were similar for mono and polyglutamylated substrates. Equilibrium dialysis studies showed that the folate substrate in a ternary complex with deoxyuridylate bound to one of the subunits (site A) with a K(d) of 720 nm. The binding of the substrate to the second subunit (site B) was much weaker, and the K(d) could not be determined by this method. However, dissociation constants for each subunit could be measured for the folate analog inhibitors, and, depending on the inhibitor, the relative K(d) value for each subunit varied substantially. For example, formyl-5,8-dideazafolate and tetraglutamylated 10-propargyl-5,8-dideazafolate bound to both sites with similar K(d) values, whereas D1694Glu4 bound to subunit A with a higher affinity (K(d) = 1.0 nM) than to subunit B (K(d) = 30 nM). In contrast, 1843U89 (mono or diglutamylated form) had a much higher affinity for subunit B (K(d) approximately 1 nM) compared with subunit A (K(d) approximately 400 nM). Enzyme inhibition kinetic analyses showed that the K(i) values of 1843U89 were quite low (0.1 nM) and that the inhibition was noncompetitive. In contrast, the other folate analogs inhibited the enzyme via mixed inhibition (i.e. both the K(m) for the folate substrate and the V(max) were altered). We conclude that the two subunits of thymidylate synthase bind folate substrates and analogs differently and that the asymmetric binding of the ligands is the major factor that determines the inhibition kinetics of each folate analog inhibitor.